Index by author

August 01, 2007; Volume 74,Issue 8

  1. Mandell, Brian F.

    1. The art and evidence of medical practice
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine August 2007, 74 (8) 544;

      A message from the Spine Patient Outcomes Research Trial (SPORT) could be that the artful judgment of a seasoned clinician, with patient input, may actually be a valid way to make decisions.

  2. Mathews, Manu

    1. Atypical antipsychotics: New drugs, new challenges
      Manu Mathews, MD and David J. Muzina, MD
      Cleveland Clinic Journal of Medicine August 2007, 74 (8) 597-606;

      Second-generation antipsychotic, or atypical, drugs are much less likely than typical antipsychotics to cause movement disorders, but they come with a new variety of side effects, particularly metabolic ones.

  3. Mazanec, Daniel

    1. Interpreting the Spine Patient Outcomes Research Trial
      Daniel Mazanec, MD and Linda Okereke, MD
      Cleveland Clinic Journal of Medicine August 2007, 74 (8) 577-583;

      The Spine Patient Outcomes Research Trial compared surgical and nonsurgical treatment in patients with radicular pain. The treatments were equivalent on intention-to-treat analysis, but up to 40% of patients in each group “crossed over” to the other treatment, muddying the results.

  4. Moayyedi, Paul

    1. Colorectal cancer screening lacks evidence of benefit
      Paul Moayyedi, BSc, MB ChB, PhD, MPH, FRCP, FRCPC
      Cleveland Clinic Journal of Medicine August 2007, 74 (8) 545-554;

      Although some studies indicate that screening with fecal occult blood testing or colonoscopy prevents deaths from colorectal cancer, the benefits may be offset by more deaths from other causes.

  5. Muzina, David J.

    1. Atypical antipsychotics: New drugs, new challenges
      Manu Mathews, MD and David J. Muzina, MD
      Cleveland Clinic Journal of Medicine August 2007, 74 (8) 597-606;

      Second-generation antipsychotic, or atypical, drugs are much less likely than typical antipsychotics to cause movement disorders, but they come with a new variety of side effects, particularly metabolic ones.

Back to top

In this issue